Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.
暂无分享,去创建一个
[1] J. Whitlock,et al. Disruption of the RanBP17/Hox11L2 region by recombination with the TCRδ locus in acute lymphoblastic leukemias with t(5;14)(q34;q11) , 2002, Leukemia.
[2] P. D. de Jong,et al. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Sklar,et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.
[4] T. Honjo,et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. , 2002, International immunology.
[5] P. Marynen,et al. In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia , 2008, Haematologica.
[6] W. Kamps,et al. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. , 2006, Haematologica.
[7] L. Girard,et al. Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. , 1996, Genes & development.
[8] S. Sabbioni,et al. t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia , 2000, British journal of haematology.
[9] Raphael Kopan,et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. , 2000, Molecular cell.
[10] F. Sigaux,et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.
[11] F. Sigaux,et al. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. , 1994, Blood.
[12] J. Aster,et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. , 1999, Immunity.
[13] S. Raimondi,et al. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). , 1991, Blood.
[14] A. Ferrando,et al. The role of NOTCH1 signaling in T-ALL. , 2009, Hematology. American Society of Hematology. Education Program.
[15] H. Macdonald,et al. Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. , 2002, Immunity.
[16] M. Surani,et al. Segmental and developmental regulation of a presumptive T-cell oncogene in the central nervous system , 1990, Nature.
[17] M. Ciofani,et al. Notch promotes survival of pre–T cells at the β-selection checkpoint by regulating cellular metabolism , 2005, Nature Immunology.
[18] P. Nowell,et al. Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. , 1986, Science.
[19] A. Gedman,et al. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss. , 2009, Blood.
[20] H. Drexler,et al. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). , 2003, Cancer research.
[21] A. Rimm,et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. , 1992, Blood.
[22] Y. Hayashi,et al. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. , 1999, Leukemia research.
[23] E. Macintyre,et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. , 2003, Blood.
[24] A. Ferrando,et al. WT1 mutations in T-ALL. , 2009, Blood.
[25] T. Honjo,et al. Regulation of lymphocyte development by Notch signaling , 2007, Nature Immunology.
[26] G. Sonenshein,et al. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. , 2006, The EMBO journal.
[27] Francois Pognan,et al. Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[28] B. Johansson,et al. Deregulation of cyclin D2 by juxtaposition with T‐cell receptor alpha/delta locus in t(12;14)(p13;q11)‐positive childhood T‐cell acute lymphoblastic leukemia , 2006, European journal of haematology.
[29] F. Speleman,et al. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951 , 2010, Leukemia.
[30] Raphael Kopan,et al. Notch signaling: from the outside in. , 2000, Developmental biology.
[31] A. Ferrando,et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia , 2007, The Journal of experimental medicine.
[32] H. Dombret,et al. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. , 2009, Blood.
[33] Peter Marynen,et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). , 2005, Blood.
[34] Malay Mandal,et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. , 2007, Nature medicine.
[35] M. Ciofani,et al. A survival guide to early T cell development , 2006, Immunologic research.
[36] G. Gustafsson,et al. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries , 1999, Bone Marrow Transplantation.
[37] Charles Lee,et al. Alu elements mediate MYB gene tandem duplication in human T-ALL , 2007, The Journal of experimental medicine.
[38] R. Espinosa,et al. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Aster,et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. , 2006, Genes & development.
[40] P. Wei,et al. Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design , 2010, Molecular Cancer Therapeutics.
[41] A. Ferrando,et al. NOTCH mutations as prognostic markers in T-ALL , 2010, Leukemia.
[42] S. Korsmeyer,et al. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. , 1991, Science.
[43] Iannis Aifantis,et al. γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia , 2009, Nature Medicine.
[44] Raymond E. Moellering,et al. Direct inhibition of the NOTCH transcription factor complex , 2009, Nature.
[45] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[46] Il-Jin Kim,et al. FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression , 2008, Science.
[47] R. Tibshirani,et al. Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. , 2007, Blood.
[48] T. Rabbitts,et al. HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[49] B. Clurman,et al. Mechanisms of Tumor Suppression by the SCFFbw7 , 2005, Cell cycle.
[50] J. Aster,et al. Notch signaling in leukemia. , 2001, Current opinion in hematology.
[51] G. Weinmaster,et al. Selective Use of ADAM10 and ADAM17 in Activation of Notch1 Signaling , 2009, Molecular and Cellular Biology.
[52] Ching-Hon Pui,et al. Acute lymphoblastic leukemia. , 2004, The New England journal of medicine.
[53] B. Nadel,et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. , 2007, Blood.
[54] C. Masters,et al. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies. , 2006, CNS drugs.
[55] M. Urashima,et al. Establishment and characteristics of a T-cell acute lymphoblastic leukemia cell line, JK-T1, with a chromosomal translocation between 8q24 and 14q13. , 1992, Cancer genetics and cytogenetics.
[56] A. Ferrando,et al. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors , 2006, Leukemia.
[57] J. Rowley,et al. Molecular analysis of the t(8;14)(q24;q11) chromosomal breakpoint junctions in the T‐cell leukemia line MOLT‐16 , 1997 .
[58] S. Reed,et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. , 2007, Cancer research.
[59] Xudong Dai,et al. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells. , 2009, Cancer research.
[60] A. Ferrando,et al. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. , 2008, Blood.
[61] A. Ferrando,et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). , 2009, Blood.
[62] E. Macintyre,et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage , 2003 .
[63] Andrew P. Stubbs,et al. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. , 2007, Blood.
[64] A. Ferrando,et al. NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia , 2009, Leukemia.
[65] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[66] S. Korsmeyer,et al. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein , 1989, Molecular and cellular biology.
[67] Hans Clevers,et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.
[68] C. Masters,et al. Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer’s Disease , 2006 .
[69] J. Sklar,et al. Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia , 1991, The Journal of experimental medicine.
[70] P. V. van Diest,et al. Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage* , 2009, The Journal of Biological Chemistry.
[71] C. Kenific,et al. Down‐regulation of the Notch pathway mediated by a γ‐secretase inhibitor induces anti‐tumour effects in mouse models of T‐cell leukaemia , 2009, British journal of pharmacology.
[72] A. Ferrando,et al. CSL–MAML-dependent Notch1 signaling controls T lineage–specific IL-7Rα gene expression in early human thymopoiesis and leukemia , 2009, The Journal of experimental medicine.
[73] J. Downing,et al. Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia , 2009, Leukemia.
[74] Andrea Califano,et al. ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes , 2007, Proceedings of the National Academy of Sciences.
[75] J. Rowley,et al. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[76] Y. Hayashi,et al. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non‐Hodgkin lymphoma , 2009, British journal of haematology.
[77] M. Bar‐eli,et al. N‐RAS mutations in T‐cell acute lymphocytic leukaemia: analysis by direct sequencing detects a novel mutation , 1989, British journal of haematology.
[78] Malay Mandal,et al. Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia , 2007, Nature Medicine.
[79] T. Shows,et al. Complex MLL rearrangement in a patient with T‐cell acute lymphoblastic leukemia , 1995, Genes, chromosomes & cancer.
[80] P. Majumder,et al. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. , 2009, Blood.
[81] I. Kirsch,et al. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. , 1990, Science.
[82] J. Aster,et al. A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] R. Berger,et al. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T‐cell leukemias , 1990, Genes, chromosomes & cancer.
[84] M. Perutz,et al. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[85] H. Macdonald,et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.
[86] Alexander D. MacKerell,et al. A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. , 2010, Cancer cell.
[87] S. Bohlander,et al. Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia , 2000, Leukemia.
[88] D. Selkoe,et al. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. , 2003, Annual review of neuroscience.
[89] M. Evans,et al. The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.
[90] M. Muckenthaler,et al. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. , 2006, Blood.
[91] A Cumano,et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. , 2000, Molecular cell.
[92] E. Petricoin,et al. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols , 2010, Leukemia.
[93] W. Ludwig,et al. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). , 1991, Oncogene.
[94] M. Cleary,et al. lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif , 1989, Cell.
[95] J. Niland,et al. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[96] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[97] E. Clappier,et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia , 2008, The Journal of experimental medicine.
[98] K. Ross,et al. Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors , 2010, PloS one.
[99] Rob Pieters,et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors , 2007, The Journal of experimental medicine.
[100] M. Bhasin,et al. Notch1 Contributes to Mouse T-Cell Leukemia by Directly Inducing the Expression of c-myc , 2006, Molecular and Cellular Biology.
[101] J. Shuster,et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. , 1994, The New England journal of medicine.
[102] S. Armstrong,et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. , 2003, Blood.
[103] J. Rowley,et al. Gene encoding the alpha chain of the T-cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human T-cell leukemia. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[104] U. Lendahl,et al. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. , 2007, Experimental cell research.
[105] J. Aster,et al. Leukemia-Associated Mutations within the NOTCH1 Heterodimerization Domain Fall into at Least Two Distinct Mechanistic Classes , 2006, Molecular and Cellular Biology.
[106] Andrew P. Weng,et al. Erratum: NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth (Proceedings of the National Academy of Sciences of the United States of America (2006) 103, 48, (18261-18266) DOI: 10.1073/pnas.0606108103) , 2007 .
[107] P. Marynen,et al. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias , 2005, Leukemia.
[108] J. V. van Dongen,et al. The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene. , 2006, Haematologica.
[109] W. Friedrich,et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. , 1991, Blood.
[110] Hans Clevers,et al. Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2 , 2008, EMBO reports.
[111] Michael Wolfe,et al. J+ = J , 1994, ACM SIGPLAN Notices.
[112] A. Ferrando,et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia , 2004, Nature Genetics.
[113] A. Sarin,et al. The Anti-apoptotic Effect of Notch-1 Requires p56lck-dependent, Akt/PKB-mediated Signaling in T Cells* , 2004, Journal of Biological Chemistry.
[114] Boris Reizis,et al. Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. , 2002, Genes & development.
[115] R. Pieters,et al. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. , 2008, Blood.
[116] S. Kamel‐Reid,et al. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) , 1991 .
[117] J. Downing,et al. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. , 1996, Blood.
[118] A. Ferrando,et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[119] U. Lendahl,et al. Notch-1 associates with IKKα and regulates IKK activity in cervical cancer cells , 2008, Oncogene.
[120] Govind Bhagat,et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia , 2007, Nature Medicine.
[121] T. Waldmann,et al. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[122] Rob Pieters,et al. PHF6 mutations in T-cell acute lymphoblastic leukemia , 2010, Nature Genetics.
[123] M. Nakagawa,et al. Translocation between chromosomes 8q24 and 14q11 in T-cell acute lymphoblastic leukemia. , 1990, Cancer genetics and cytogenetics.
[124] A. Ferrando,et al. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. , 2000, Seminars in hematology.
[125] Thijs J. Hagenbeek,et al. Therapeutic antibody targeting of individual Notch receptors , 2010, Nature.
[126] M. Lu,et al. The tcl‐3 proto‐oncogene altered by chromosomal translocation in T‐cell leukemia codes for a homeobox protein. , 1991, The EMBO journal.
[127] J. Aster,et al. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. , 2008, The Journal of clinical investigation.
[128] 藤井 洋. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation , 2006 .
[129] Charles Lee,et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. , 2006, Blood.
[130] A. Ferrando,et al. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. , 2003, Cancer cell.
[131] J. Aster,et al. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. , 2009, Blood.
[132] Rob Pieters,et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia , 2007, Nature Genetics.
[133] A. Carroll,et al. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix‐loop‐helix protein. , 1990, The EMBO journal.
[134] Adam A. Margolin,et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth , 2006, Proceedings of the National Academy of Sciences.
[135] J. Aster,et al. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. , 2008, Blood.
[136] F. Sigaux,et al. Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias , 2006, Leukemia.
[137] G. Sonenshein,et al. Notch1 augments NF‐κB activity by facilitating its nuclear retention , 2006 .
[138] D J Hussey,et al. The (4;11)(q21;p15) translocation fuses the NUP98 and RAP1GDS1 genes and is recurrent in T-cell acute lymphocytic leukemia. , 1999, Blood.
[139] P. Nowell,et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.